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Ptosis on its own is an infrequent initial manifestation of
orbital lymphoma [1]. Orbital lymphoma usually presents
with proptosis, periorbital swelling, conjunctival (“salmon-
pink”) swelling, diplopia, and conjunctival redness and
irritation [2–6]. It can remain indolent for a long period of
time before the patient notices the periorbital abnormality
[2–6]. Often seen are proptotic cases in association with
various degrees of ptosis. Here we report an unusual
presentation of orbital lymphoma with an initial
manifestation of ptosis on its own.
CASE PRESENTATION
A 62-year-old woman was sent for consultation for right
eye ptosis and mild ocular pain that began about 1 month
earlier (Figure 1). Margin reflex distance (MRD) was 1 mm
on the right eye and 6 mm on the left. The levator muscle
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Ptosis on its own is an infrequent initial manifestation of orbital lymphoma. Orbital lymphoma usually
presents as a palpable mass with proptosis, diplopia, and conjunctival (“salmon-pink”) swelling. We report
here a 62-year-old female patient who presented with right eye ptosis. The initial imaging study showed an
indistinct enlargement of the superior rectus–levator muscle complex. After 3–4 months, ptosis and upward
gazing movement were further restricted. The imaging study revealed a definite soft-tissue mass in the
superior orbit surrounding the superior rectus–levator muscle complex. A tumor biopsy through anterior
orbitotomy revealed a large diffuse B-cell lymphoma. With the experience of this case, we suggest that orbital
lymphoma should be included in the differential diagnosis of ptosis accompanied by impairment of levator
muscle function.
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function was 8 mm on the right eye and 15 mm on the left.
The supraduction of the right eye was mildly limited. There
was neither proptosis nor diplopia. An initial computed
tomography (CT) scan (Figure 2) and magnetic resonance
imaging (MRI) of the orbit and brain revealed an indistinct
mass in the superior orbit close to, or within, the superior
rectus–levator muscle complex. The neostigmine test and
anti-acetylcholine antibody were both negative. She was
treated with prednisolone 15 mg/day and pyridostigmine
bromide (Mestinon) by the neurologist who thought the
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Figure 1. Patient presented with right eyelid ptosis. Margin reflex
distance was 1 mm on the right eye and 6 mm on the left eye. Levator
muscle function was 8 mm in the right eye and 15 mm in the left eye.
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patient was suffering from myasthenia gravis. During the
2-month period of treatment, the ptosis progressed. The
MRD measured 1 mm on the right eye. Without strong
evidence of an orbital mass lesion, orbitotomy for orbital
exploration under general anesthesia was not strongly
considered. After discussion with the patient, an exploration
of the anterior orbit, in combination with a levator muscle
resection to correct ptosis, was performed under local
anesthesia. Histopathologic examination showed
inflammation only. Five months later, supraduction was
further limited, and the ptosis recurred after levator
resection. The second CT scan and MRI (Figure 3) of the
orbit revealed a definite soft-tissue mass in the superior
orbit surrounding the superior rectus–levator muscle
complex. A tumor biopsy via anterior orbitotomy revealed
a large diffuse B-cell lymphoma. Immunohistochemistry
showed that the malignant cells were CD20 positive and
CD3 negative (Figure 4). Stage IEA (Ann Arbor criteria)
was determined after detailed systemic survey. The patient
received a complete therapeutic course of chemotherapy
with a regimen of cyclophosphamide, epirubicin, oncovin
and prednisolone, and monoclonal antibody therapy (anti-
CD20 antibody). A follow-up CT scan showed that the
orbital mass had disappeared (Figure 5). However, the
right eye ptosis did not improve, with an MRD of –3 mm
and very limited levator muscle function. The supraduction
was mildly limited.
DISCUSSION
The patient in this case presented predominantly with
ptosis. The imaging study did not show a clear orbital mass,
but only a mild enlargement of the superior rectus–levator
muscle complex. However, the slight suspicion of an orbital
tumor did not justify the performance of an invasive
diagnostic exploration of the orbit via orbitotomy under
general anesthesia. The lesion could have been an
inflammation or a benign reactive lymphoid hyperplasia.
In cases of inflammation, the use of immunosuppression or
anti-inflammatory treatment might be of help, whereas
surgical intervention could be detrimental to levator function
of the eyelid or supraduction of the eyeball.
Prednisolone had been tried as the initial treatment. In
cases of myasthenia gravis or idiopathic orbital
inflammatory syndrome, steroid treatment can be of help
[7,8]. However, the ptosis in this patient did not improve,
and supraduction limitation developed. Therefore, a follow-
up CT scan was performed, and a definite orbital mass was
Figure 2. A soft-tissue mass was indistinctly visible in the superior
orbit surrounding or within the superior rectus–levator muscle complex.
Figure 3. MRI scan of the orbit revealed a definite soft-tissue mass
in the superior orbit surrounding the superior rectus–levator muscle
complex.
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Figure 4. Microscopically, the soft tissue is infiltrated by large monotonous lymphoid cells diffusely. They have hyperchromatic or vesicular
nuclei. There are foci of punctate necrosis and mitotic activity (A, B). The immunohistochemical stain demonstrates: CD3– (C) and CD20+ (D).
identified. Only at this point was the ophthalmologist
comfortable with advising the patient to have the invasive
diagnostic surgery. Nevertheless, initiation of the treatment
for orbital lymphoma at that point was not too late. The
patient had a complete remission of the tumor after
chemotherapy.
On CT scan, orbital lymphoma usually appears as a
homogeneous molding mass with sharp margins, most
often localized in the anterior portion of the orbit, the
retrobulbar area, or the superior orbital compartment
[9,10]. The tumor mass rarely erodes bones and does not
cause much disturbance of ocular motility, lid excursion,
or visual function. More oppressive forms that infiltrate
the orbit and erode bone are also possible, but are unusual
[11,12]. A case of isolated orbital lymphoma presenting as
blindness with an unusual feature of bone erosion has
been reported [13].
Orbital lymphomas arising from extraocular muscles
are unusual. Hornblass et al reported six cases of orbital
lymphoma with similar symptoms [1], which were
ptosis or supraduction disturbance overshadowing
exophthalmos. The lesions were all located within the
superior rectus–levator muscle complex. Lymphoma
located within the extraocular muscles (EOM) has been
called “EOM lymphoma”[14]. The most common
presenting complaints of such lymphoma have been
diplopia, ptosis, and lid fullness [1,14–17], whereas pain,
conjunctival vasocongestion, or lid erythema are not typical
features. Involvement of the superior rectus–levator muscle
complex was the most common manifestation [15],
followed by involvement of the medial rectus [1,16] and
lateral rectus muscles [1]. Involvement of the inferior
oblique muscle [14,17] has occasionally been observed
as well.
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This case presented a situation of symptom manifestation
earlier than confirmed by imaging evidence. The decision
to intervene surgically for diagnosis is always debatable.
However, close follow-up is the best policy. EOM lymphoma
should always be considered within the differential
diagnosis of ptosis.
REFERENCES
1. Hornblass A, Jakobiec FA, Reifler DM, et al. Orbital lymphoid
tumors located predominantly within extraocular muscles.
Ophthalmology 1987;94:688–97.
2. Van der Gaag R, Koornneef L, van Heerde P, et al. Lymphoid
proliferations in the orbit: malignant or benign? Br J Ophthalmol
1984;68:892–900.
3. Sarah EC, Michael H, Harald S. Ocular adnexal lymphomas:
five case presentations and a review of the literature. Survey
Ophthalmol 2002;47:470–90.
4. Tranfa F, Di Matteo G, Strianese D, et al. Primary orbital
lymphoma. Orbit 2001;20:119–24.
5. Coupland SE, Krause L, Delecluse HJ, et al. Lymphoproliferative
lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology
1998;105:1430–41.
6. McKelvie PA, McNab A, Francis IC, et al. Ocular adnexal
lymphoproliferative disease: a series of 73 cases. Clin Exp
Ophthalmol 2001;29:387–93.
7. Jacobs D, Galetta S. Diagnosis and management of orbital
pseudotumor. Curr Opin Ophthalmol 2002;13:347–51.
8. Porter NC, Salter BC. Ocular myasthenia gravis. Curr Treat
Options Neurol 2005;7:79–88.
9. Valvassori GE, Sabnis SS, Mafee RF, et al. Imaging of orbital
lymphoproliferative disorders. Radiol Clin North Am 1999;
37:135–50.
10. Westacott S, Garner A, Moseley IF, et al. Orbital lymphoma
versus reactive lymphoid hyperplasia: an analysis of the use
of computed tomography in differential diagnosis. Br J
Ophthalmol 1991;75:722–5.
11. Leidenix MJ, Mamalis N, Olson RJ, et al. Primary T-cell
immunoblastic lymphoma of the orbit in a pediatric patient.
Ophthalmology 1993;100:998–1002.
12. Arnold AC, La Masters DL. Foraminal expansion by malignant
retroorbital lymphoma: CT findings. J Comput Assist Tomogr
1987;11:730–2.
13. Kuriakose M, Llewelyn J, Sugar A. Orbital lymphoma:
blindness as a presenting symptom. Br J Oral Maxillofac Surg
1992;30:168–70.
14. Kert G, Clement CI, O’Donnell BA. Orbital lymphoid tumour
located within an extraocular muscle. Clin Exp Ophthalmol
2004;32:651–2.
15. George JL, Quercia P, Hachet E, et al. Non-Hodgkin’s malignant
lymphoma of the rectus superior oculi muscle causing a
deficit of the elevation. Bull Soc Ophthalmol Fr 1986;5:721–2.
16. Arai N, Hara A, Umeda M, et al. Non-Hodgkin’s lymphoma
localised at the right ocular medial rectal muscle. Jpn J Clin
Haematol 1991;32:52–5.
17. Curutchet L, Gicquel JJ, Adenis JP, et al. Lymphoma revealed
by isolated obliquus inferior muscle involvement in
exophthalmia. J Fr Ophthalmol 2003;26:626–30.
Figure 5. Follow-up CT scan after chemotherapy showed that the
orbital mass had disappeared.
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